Log in

Magenta Therapeutics News Headlines (NASDAQ:MGTA)

$12.35
+0.31 (+2.57 %)
(As of 02/17/2020 06:56 AM ET)
Today's Range
$11.92
Now: $12.35
$12.53
50-Day Range
$11.79
MA: $13.67
$15.26
52-Week Range
$8.48
Now: $12.35
$21.00
Volume55,948 shs
Average Volume84,991 shs
Market Capitalization$481.53 million
P/E RatioN/A
Dividend YieldN/A
Beta3.35

Headlines

Magenta Therapeutics (NASDAQ MGTA) News Headlines

Source:
DateHeadline
3 Monster Growth Stocks That Can Charge Forward in 20203 Monster Growth Stocks That Can Charge Forward in 2020
finance.yahoo.com - February 16 at 8:37 AM
Magenta Therapeutics to Participate in Guggenheim Healthcare Talks Oncology Day on Thursday, February 13 th in New York CityMagenta Therapeutics to Participate in Guggenheim Healthcare Talks Oncology Day on Thursday, February 13 th in New York City
www.businesswire.com - February 6 at 12:43 PM
Magenta Therapeutics to Participate in Guggenheim Healthcare Talks Oncology Day on Thursday, February 13th in New York CityMagenta Therapeutics to Participate in Guggenheim Healthcare Talks Oncology Day on Thursday, February 13th in New York City
finance.yahoo.com - February 6 at 12:43 PM
Magenta Therapeutics Expands Leadership Team, Appoints Kristen Stants as Chief People Officer and Li Malmberg as Senior Vice President, Head of ManufacturingMagenta Therapeutics Expands Leadership Team, Appoints Kristen Stants as Chief People Officer and Li Malmberg as Senior Vice President, Head of Manufacturing
finance.yahoo.com - February 5 at 9:28 AM
Financial Survey: IMMUTEP LTD/S (NASDAQ:IMMP) vs. Magenta Therapeutics (NASDAQ:MGTA)Financial Survey: IMMUTEP LTD/S (NASDAQ:IMMP) vs. Magenta Therapeutics (NASDAQ:MGTA)
www.americanbankingnews.com - February 3 at 3:21 PM
-$0.58 Earnings Per Share Expected for Magenta Therapeutics Inc (NASDAQ:MGTA) This Quarter-$0.58 Earnings Per Share Expected for Magenta Therapeutics Inc (NASDAQ:MGTA) This Quarter
www.americanbankingnews.com - February 3 at 9:46 AM
Magenta Therapeutics Inc (NASDAQ:MGTA) Receives Average Rating of "Hold" from AnalystsMagenta Therapeutics Inc (NASDAQ:MGTA) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - January 30 at 5:46 AM
Magenta Therapeutics Advances Conditioning Platform and Clinical Programs, Highlights Recent Milestones and 2020 GoalsMagenta Therapeutics Advances Conditioning Platform and Clinical Programs, Highlights Recent Milestones and 2020 Goals
finance.yahoo.com - January 13 at 4:24 PM
Magenta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15th in San FranciscoMagenta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15th in San Francisco
finance.yahoo.com - January 6 at 5:00 PM
Did Hedge Funds Drop The Ball On Magenta Therapeutics, Inc. (MGTA) ?Did Hedge Funds Drop The Ball On Magenta Therapeutics, Inc. (MGTA) ?
finance.yahoo.com - December 19 at 10:16 PM
Magenta up 15% on promising data on ADC conditioning agentMagenta up 15% on promising data on ADC conditioning agent
seekingalpha.com - December 10 at 1:14 PM
Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug ConjugateMagenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug Conjugate
finance.yahoo.com - December 9 at 8:38 AM
Magenta Therapeutics, Inc. Common Stock (MGTA) Institutional HoldingsMagenta Therapeutics, Inc. Common Stock (MGTA) Institutional Holdings
www.nasdaq.com - November 28 at 6:08 PM
Magenta Therapeutics to Present at the Evercore ISI HealthCONx Conference on Tuesday, December 3rdMagenta Therapeutics to Present at the Evercore ISI HealthCONx Conference on Tuesday, December 3rd
finance.yahoo.com - November 26 at 8:28 PM
MGTA Magenta Therapeutics, Inc. Common StockMGTA Magenta Therapeutics, Inc. Common Stock
www.nasdaq.com - November 21 at 8:59 AM
Magenta Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business HighlightsMagenta Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - November 13 at 12:37 PM
Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACRMagenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR
finance.yahoo.com - November 11 at 12:52 PM
Magenta Therapeutics, Inc. Common Stock (MGTA) After-Hours QuotesMagenta Therapeutics, Inc. Common Stock (MGTA) After-Hours Quotes
www.nasdaq.com - November 7 at 12:33 AM
Magenta Therapeutics to Present New Clinical and Preclinical Data at American Society of Hematology (ASH) Annual MeetingMagenta Therapeutics to Present New Clinical and Preclinical Data at American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - November 6 at 9:31 AM
Magenta Therapeutics, Inc. (MGTA) Is Burning These Hedge FundsMagenta Therapeutics, Inc. (MGTA) Is Burning These Hedge Funds
finance.yahoo.com - October 30 at 12:20 PM
Magenta Therapeutics Sees Hammer Chart Pattern: Time to Buy?Magenta Therapeutics Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - October 9 at 9:26 AM
Did Magenta Therapeutics, Inc. (NASDAQ:MGTA) Insiders Sell Shares?Did Magenta Therapeutics, Inc. (NASDAQ:MGTA) Insiders Sell Shares?
finance.yahoo.com - October 8 at 11:11 AM
FDA grants RMAT tag for Magenta cell therapy for inherited metabolic disordersFDA grants RMAT tag for Magenta cell therapy for inherited metabolic disorders
seekingalpha.com - September 4 at 3:58 PM
Magenta Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to MGTA-456 for the Treatment of Inherited Metabolic DisordersMagenta Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to MGTA-456 for the Treatment of Inherited Metabolic Disorders
finance.yahoo.com - September 4 at 3:58 PM
Magenta Therapeutics: Valuation Remains Under Pressure With Lack Of Catalysts, But Promise RemainsMagenta Therapeutics: Valuation Remains Under Pressure With Lack Of Catalysts, But Promise Remains
seekingalpha.com - August 16 at 4:04 PM
Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business HighlightsMagenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - August 8 at 9:26 AM
CORRECTING and REPLACING Magenta Therapeutics Appoints Anne McGeorge to Board of DirectorsCORRECTING and REPLACING Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
finance.yahoo.com - July 12 at 3:45 PM
Magenta Therapeutics Appoints Anne McGeorge to Board of DirectorsMagenta Therapeutics Appoints Anne McGeorge to Board of Directors
finance.yahoo.com - June 25 at 12:02 PM
Can You Imagine How Magenta Therapeuticss (NASDAQ:MGTA) Shareholders Feel About The 12% Share Price Increase?Can You Imagine How Magenta Therapeutics's (NASDAQ:MGTA) Shareholders Feel About The 12% Share Price Increase?
finance.yahoo.com - June 22 at 11:29 AM
Can You Imagine How Magenta Therapeutics's (NASDAQ:MGTA) Shareholders Feel About The 12% Share Price Increase?Can You Imagine How Magenta Therapeutics's (NASDAQ:MGTA) Shareholders Feel About The 12% Share Price Increase?
finance.yahoo.com - June 22 at 11:29 AM
Magenta Therapeutics to Present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11thMagenta Therapeutics to Present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11th
finance.yahoo.com - June 7 at 4:26 PM
Magenta Therapeutics: Targeted Conditioning Agents Drive Long-Term UpsideMagenta Therapeutics: Targeted Conditioning Agents Drive Long-Term Upside
seekingalpha.com - May 30 at 11:51 AM
Magenta Therapeutics Reports First Quarter 2019 Financial Results and Recent Business HighlightsMagenta Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - May 9 at 12:00 PM
Magenta Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesMagenta Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - May 7 at 11:50 AM
Magenta prices equity offering; shares down 2% premarketMagenta prices equity offering; shares down 2% premarket
seekingalpha.com - May 2 at 12:01 PM
Magenta Therapeutics Launches Proposed Public OfferingMagenta Therapeutics Launches Proposed Public Offering
finance.yahoo.com - April 30 at 11:39 AM
Magenta Therapeutics to Present Preclinical Data on E478 Stem Cell Gene Therapy Expansion Program at the 2019 Annual Meeting of the American Society of Gene and Cell TherapyMagenta Therapeutics to Present Preclinical Data on E478 Stem Cell Gene Therapy Expansion Program at the 2019 Annual Meeting of the American Society of Gene and Cell Therapy
finance.yahoo.com - April 29 at 11:38 AM
Magenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product CandidateMagenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate
finance.yahoo.com - April 24 at 11:59 AM
Magenta Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business HighlightsMagenta Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights
finance.yahoo.com - March 19 at 9:43 AM
How Many Insiders Bought Magenta Therapeutics, Inc. (NASDAQ:MGTA) Shares?How Many Insiders Bought Magenta Therapeutics, Inc. (NASDAQ:MGTA) Shares?
finance.yahoo.com - March 16 at 12:26 PM
Raymond James sees 73% upside in Magenta TherapeuticsRaymond James sees 73% upside in Magenta Therapeutics
seekingalpha.com - March 15 at 3:48 PM
Magenta Therapeutics to Present at Investor Conferences in MarchMagenta Therapeutics to Present at Investor Conferences in March
finance.yahoo.com - March 7 at 12:41 PM
Magenta up 7% on cell therapy dataMagenta up 7% on cell therapy data
seekingalpha.com - February 25 at 3:54 PM
Magenta Therapeutics Presents Clinical and Preclinical Data on MGTA-456 Cell Therapy in Best Abstracts Sessions at Transplant and Cellular Therapy (TCT) Annual MeetingMagenta Therapeutics Presents Clinical and Preclinical Data on MGTA-456 Cell Therapy in Best Abstracts Sessions at Transplant and Cellular Therapy (TCT) Annual Meeting
finance.yahoo.com - February 25 at 10:47 AM
Magenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs, Including First Conditioning Development CandidateMagenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs, Including First Conditioning Development Candidate
finance.yahoo.com - February 25 at 10:47 AM
Magenta Therapeutics Presents Preclinical Data on MGTA-145, First-Line Stem Cell Mobilization Product Candidate for Autologous and Allogeneic Bone Marrow TransplantMagenta Therapeutics Presents Preclinical Data on MGTA-145, First-Line Stem Cell Mobilization Product Candidate for Autologous and Allogeneic Bone Marrow Transplant
finance.yahoo.com - February 21 at 12:55 PM
Magenta Therapeutics to Present at Guggenheim Healthcare Investor ConferenceMagenta Therapeutics to Present at Guggenheim Healthcare Investor Conference
finance.yahoo.com - February 7 at 11:27 AM
Magenta Therapeutics Inc.Magenta Therapeutics Inc.
www.barrons.com - January 28 at 3:42 PM
Magenta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019Magenta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019
finance.yahoo.com - January 2 at 10:27 AM
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel